Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined use of six-well polystyrene plates and thin layer chromatography for rapid development of optimal plant cell culture processes: application to taxane production byTaxus sp.

Plant cell reports·2019
Same author

The role of body-on-a-chip devices in drug and toxicity studies.

Annual review of biomedical engineering·2011
Same author

Fabrication and optimization of alginate hydrogel constructs for use in 3D neural cell culture.

Biomedical materials (Bristol, England)·2011
Same author

A cell culture analogue of rodent physiology: Application to naphthalene toxicology.

Toxicology in vitro : an international journal published in association with BIBRA·2010
Same author

On the Birth of BIOTECHNOLOGY PROGRESS.

Biotechnology progress·2010
Same author

Continuous Immobilized Recombinant Protein Production from E. coli Capable of Selective Protein Excretion: A Feasibility Study.

Biotechnology progress·2010

Related Experiment Video

Updated: Jun 10, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Different In Vitro Systems Affect CYPIA1 Activity in Response to 2,3,7,8-Tetrachlorodibenzo-p-dioxin.

N A Mufti1, M L Shuler

  • 1School of Chemical Engineering, Cornell University, Ithaca, New York, 14853-5201, USA.

Toxicology in Vitro : an International Journal Published in Association with BIBRA
|July 27, 2010
PubMed
Summary

A new cell culture system using a two-compartment model better mimics human exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). This advanced model provides a more accurate risk assessment for TCDD exposure compared to traditional methods.

More Related Videos

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

Related Experiment Videos

Last Updated: Jun 10, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
09:50

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke

Published on: February 12, 2015

Area of Science:

  • Environmental Toxicology
  • Cellular Biology
  • Biochemical Pharmacology

Background:

  • Cytochrome P450IA1 (CYP1A1) induction in human hepatoma cells models exposure to environmental contaminants like 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
  • CYP1A1 induction is regulated by the intracellular Ah receptor, a key mediator in toxicological responses.
  • Traditional static in vitro exposures may not accurately reflect continuous, low-dose exposures experienced by humans.

Purpose of the Study:

  • To develop and evaluate a cell culture analogue system that simulates time-dependent, low-dose TCDD exposure.
  • To compare risk assessment outcomes between static and dynamic in vitro exposure systems.
  • To investigate the influence of in vitro system design on estimating TCDD's toxicological impact.

Main Methods:

  • A two-compartment cell culture model was designed, comprising a 'liver' compartment (HepG2 cells) and an 'other tissues' compartment.
  • HepG2 cells on microcarriers were exposed to TCDD using spinner flasks (static), a one-compartment reactor (continuous), and a two-compartment reactor (continuous).
  • Ethoxyresorufin-o-deethylase (EROD) activity was measured to quantify CYP1A1 induction, and (3)H-TCDD was used to estimate cell-associated TCDD and bound Ah receptor.

Main Results:

  • The EC(50) for EROD induction decreased significantly with system complexity: 1.49nm (spinner flask), 0.69nm (one-compartment), and 0.05nm (two-compartment).
  • CYP1A1-mediated EROD activity correlated directly with the estimated amount of bound Ah receptor across all tested systems.
  • Risk assessment estimates varied dramatically, with the two-compartment model yielding a much lower allowable TCDD exposure (1x10(-5)nm) for a 0.01% maximal response compared to static models.

Conclusions:

  • The design of in vitro exposure systems significantly impacts toxicological risk assessment outcomes for TCDD.
  • The two-compartment cell culture analogue system provides a more sensitive and realistic evaluation of low-dose TCDD exposure effects.
  • This study highlights the critical need for dynamic exposure models in accurately assessing environmental contaminant risks.